Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.
- DOI
- 10.1158/0008-5472.can-05-4620
- Published
- 2006 Jun 1
- Container
- Cancer research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/0008-5472.can-05-4620,
title = {Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.},
author = {Song L and Morris M and Bagui T and Lee FY and Jove R and Haura EB},
year = {2006},
journal = {Cancer research},
doi = {10.1158/0008-5472.can-05-4620},
url = {https://doi.org/10.1158/0008-5472.can-05-4620}
}RIS
TY - JOUR TI - Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. AU - Song L AU - Morris M AU - Bagui T AU - Lee FY AU - Jove R AU - Haura EB PY - 2006 JO - Cancer research DO - 10.1158/0008-5472.can-05-4620 UR - https://doi.org/10.1158/0008-5472.can-05-4620 ER -
APA
L, S., M, M., T, B., FY, L., R, J., & EB, H. (2006). Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.. Cancer research. https://doi.org/10.1158/0008-5472.can-05-4620
Source records
- pubmed · retrieved 2026-09-26T01:32:25.776Z